China Merchants Securities Co., Ltd.'s verification opinion on differential dividends of Shanghai Cathay Biotech Inc.
CITIC Securities Co., Ltd.'s verification opinion on the differential dividend issue of Shanghai Cathay Biotechnology Inc.
Announcement of Resolutions from the 20th Meeting of the Second Board of Directors.
Announcement of Resolutions of the 18th Meeting of the Second Board of Supervisors.
Announcement Regarding the Re-hiring of Accounting Firm.
Shanghai Kaisai Biotechnology Co., Ltd. Non-recurring profit and loss certification report
Announcement of Resolutions of the 17th Meeting of the Second Board of Supervisors
Tianjian Certified Public Accountants (Special General Partnership) Audit Report on the Use of Funds Previously Raised by Shanghai Kaisai Biotechnology Co., Ltd.
Report on the use of funds raised last time
Announcement on holding the 2023 Annual Results Briefing
CITIC Securities Co., Ltd.'s 2023 Continuous Supervision Work Site Inspection Report on Shanghai Kaisai Biotechnology Co., Ltd.
2023 Social Responsibility Report
Tianjian Certified Public Accountants (Special General Partnership) Audit Report on the Company's Internal Control
Performance Evaluation Report on Tianjian Certified Public Accountants (Special General Partnership)
2023 Independent Director Debriefing Report (Wu Xiangyang)
Tianjian Certified Public Accountants (Special General Partnership) Special Audit Report on the Summary of Non-operating Capital Occupation and Other Related Capital Transactions of Shanghai Kaisai Biotechnology Co., Ltd.
2023 Independent Director Debriefing Report (Zhang Bing)
China Merchants Securities Co., Ltd.'s 2023 Continuous Supervision Work Site Inspection Report on Shanghai Kaisai Biotechnology Co., Ltd.
Announcement of Resolutions of the 16th Meeting of the Second Board of Supervisors
Special report on the storage and actual use of funds raised in 2023
No Data